Unternehmen Nextage Therapeutics Ltd TEL AVIV STOCK EXCHANGE
Aktien
NXTG
IL0004330119
NXTG
Biotechnologie
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Abraham Dreazen
CEO | Chief Executive Officer | 40 | 12.08.20 |
Ishai Gandelsman
DFI | Director of Finance/CFO | 61 | 10.07.22 |
General Counsel | 53 | 12.08.20 | |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | 01.01.94 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Yaacov Elinav
BRD | Director/Board Member | 79 | 12.08.20 |
Israel Makov
CHM | Chairman | 85 | 21.11.11 |
Ron Grupel
BRD | Director/Board Member | 73 | 13.10.14 |
Jakob Ripshtein
BRD | Director/Board Member | 57 | 12.08.20 |
Orna Dreazen
BRD | Director/Board Member | 69 | 12.08.20 |
Director/Board Member | 59 | 12.08.20 | |
Director/Board Member | 72 | 12.08.20 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 33 268 639 | 5 155 250 ( 15,50 %) | 0 | 15,50 % |
Unternehmenskontakt
NEXTAGE Therapeutics Ltd.
Einstein Street, Building 13B Weizmann Science Park
7403617, Ness Ziona
+
http://www.nxtg.co.il![Straße Nextage Therapeutics Ltd(NXTG)](https://cdn.zonebourse.com/static/address/120960937.png)
Sektor
% 1. Jan. | Kap. | |
---|---|---|
-40.31% | 8.15 Mrd. | |
+8.65% | 3.6 Mrd. | |
-0.25% | 2.27 Mrd. | |
-24.56% | 1.9 Mrd. | |
-18.21% | 1.72 Mrd. | |
+5.95% | 922 Mio. | |
+16.75% | 731 Mio. | |
-10.48% | 679 Mio. | |
-0.60% | 288 Mio. |